Opinion

opinion

To regulate or not to regulate? You already know the answer...

 

New regulations governing the online sale of high risk drugs are stirring debate among stakeholders. Is the market for weight-loss jabs as safe as it should be?

analysis

From a lawyer: Online regulations - exactly what has changed?

The publication of revised “Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet” was not a surprise...

opinion

Community pharmacy is challenging - especially when the community is in the Himalayas

 
• By 

Treacherous terrains, monsoons, weak infrastructure – how does a corporate with a conscience balance profitability with dispensing medicine up in the mountains of Bhutan?


Pharmacy’s predicament: a psychosocial perspective

 
• By 

Pharmacy often finds itself relegated to a secondary position in the NHS. How can a profession so deeply intertwined with human health become so undervalued?

opinion

Editorial: Trump invades Greenland, Novo Nordisk rides to the rescue?

 

As community pharmacy hotly debates whether weight-loss jabs are regulated closely enough, does weight-loss wonder Novo Nordisk have bigger things to worry about?

opinion

We just bought 45 pharmacies - now we have an urgent need for Hub and Spoke

 
• By 

As a pharmacy group that has acquired over 45 companies within the past 16 months, implementing a hub and spoke model of dispensing would allow us to create much needed capacity in our stores.


exclusive

Political Pills: What do I think of the government’s response to the pharmacy inquiry?

 
• By 

The response to the pharmacy inquiry is largely a story of future promise - not promises made. Some may feel this is a movie we’ve seen before...

AI is storming ahead. Suddenly, I feel uneasy...

 
• By 

Hopefully, the immense internet has taught AI an overlapping collection of norms, incentives and reward and punishment mechanisms that invisibly teach the difference between right and wrong. Sociologist Pierre Bourdieu called them “doxa”.

exclusive

David Vanns: ‘I have deep angst... we are caught in a trap’

 
• By 

As industry giant David Vanns moves into an advisory role at Weldricks after three decades with the company, he shares his thoughts on funding negotiations, DSPs, hub and spoke, and the future for pharmacy’s family businesses in an exclusive Q&A with C+D...


Editor’s Opinion: Good news, the only way is up. Right?

 

What if the government has been working on a package of pharmacy contract reforms that would give the industry the structured and reassuring lift it deserves?

From our Martian correspondent: medicines own Earthlings

 
• By 

This ethnographic study explores the dominion of medicines and the curious behaviours of their devoted acolytes, as well as the sick and healthy Earthlings enthralled by them.

xrayser

Xrayser: Santa baby, here is what I would really love...

 
• By 

It’s that time of year again, it always seems to come around so quickly. Everything feels sparkly, glittery and christmassy, but in the world of community pharmacy it all feels a bit dark and gloomy. But...


exclusive

‘I’ve still got a fat man’s brain’: PharmaDoctor’s CEO speaks about his Mounjaro journey

 
• By 

Mounjaro has been an “overwhelmingly positive experience” for PharmaDoctor’s chief executive Graham Thoms, but he stresses it’s neither a “magic bullet” nor a “short-term fix” and that uniform regulation must be implemented.

Truly, your opinion counts. Let us know your thoughts...

 

We want to hear the important things you have to say about life in pharmacy today...

exclusive

Paul Rees: Why have I chosen to leave the NPA?

 
• By 

It was in the autumn of last year I became the NPA chief executive – and now, after an amazing period in post, I am set to move on, in mid-January, to lead the Nursing and Midwifery Council. Why have I chosen to leave the NPA? I will come back to that at the end of the article...


exclusive

Political Pills: The fate of pharmacy is inseparable from the government’s Ten Year Plan...

 
• By 

I’ve been behind Stephen Kinnock’s desk, and I know the advice he will have received on Hub & Spoke. It goes something like this… “Minister, Number 10 doesn’t want us to proceed with this until..."

opinion

Editorial: Pharmacy is a perpetual victim of someone else’s confusion

 

Labour – remarkably – still has some way to go before it plumbs the depths reached by the Conservatives. But it is trying.

From a banker: What the budget means for community pharmacy

 
• By 

This broad investment in the NHS will be most impactful, but only if matched with effective community care services on the frontline...


We can’t Wegovy our way out of the diabesity crisis...

 
• By 

"The GLP1s are relatively new and are being rolled-out as scale. We have no idea what damage 20 years of drug-induced hyper-incretin-aemia may cause, but the history of abandoned slimming drugs tells me it won’t end well."

England’s pharmacy market analysed: “A few drugs can make the difference in making a profit.”

 
• By 

With the NHS under significant pressure, there’s a real opportunity here for pharmacies to support overstretched GP and hospital services - if they’re given the proper support.